
“For the second time in recent months, a scientific paper published in a peer-reviewed journal has thoroughly rebutted the present Schedule I status of cannabis under US federal law. According to a just published review in the German scientific journal Deutsches Ärzteblatt International, scientific findings from over 100 controlled clinical trials involving either cannabis or its constituents provide ‘clear evidence that cannabinoids are useful for the treatment of various medical conditions.'”
Related posts:
In Argentina, there’s a gorgeous apartment for sale and it only costs 409 Bitcoins
Obama's Half-Brother Linked To Muslim Brotherhood
What is the Money Supply?
Now’s a Terrible Time to Own This Popular Investment
'Legitimate Wiretapping'
California seeks bans on flamethrowers and flame retardants alike
Oracle security chief to customers: Stop checking our code for vulnerabilities
Caterpillar Punked By Chinese Fraud, To Write Off Half Of Q4 Earnings
9/11 anti-sledding provision repealed in $1.15 trillion federal spending deal
Supreme Court refuses to take up challenge against New York public gun law
Berkeley, CA Replacing Municipal Debt With Blockchain Crowdfunding
Patent stunner: Nation’s most notorious “troll” sues federal gov’t
Florida City Forced To Drop $10,000+ In Fines Against Home's 'Starry' Paint Job
Gold's Black Market?
The NYPD Goes After Another Cop Who Secretly Recorded His Boss